Screener
Arrowhead Research ARWR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Arrowhead Research in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000879407-26-000047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | Six Months Ended March 31, 2026 | Six Months Ended March 31, 2025 |
|---|---|---|---|---|
| Income tax expense | 7 | 1,753 | 35 | 1,856 |
| Net (loss) income including noncontrolling interest | $(137,572) | $367,863 | $(109,328) | $192,645 |
| Net loss attributable to noncontrolling interest, net of tax | (4,840) | (2,582) | (7,409) | (4,715) |
| Net (loss) income attributable to Arrowhead Pharmaceuticals, Inc. | $(132,732) | $370,445 | $(101,919) | $197,360 |
| Net (loss) income per share attributable to Arrowhead Pharmaceuticals, Inc.: | ||||
| Basic | $(0.93) | $2.78 | $(0.73) | $1.53 |
| Diluted | $(0.93) | $2.75 | $(0.73) | $1.52 |
| Weighted-average shares used in calculating |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Arrowhead Research's net income?
- Arrowhead Research (ARWR) reported net income of -$132.73M in Q1 2026.
- How has Arrowhead Research's net income changed year-over-year?
- Arrowhead Research's net income decreased by 135.8% year-over-year, from $370.45M to -$132.73M.
- What is the long-term trend for Arrowhead Research's net income?
- Over 4 years (2021 to 2025), Arrowhead Research's net income has grown at a -67.2% compound annual growth rate (CAGR), from -$140.85M to -$1.63M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Arrowhead Research's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude